Getting the Vaccine

While type 1 diabetes (T1D) is not specified in the Advisory Committee on Immunization Practices (ACIP) vaccine priority recommendations, it does meet the identified criteria for medical conditions that increase the risk for severe COVID-19.

Several high-quality studies document that T1D impacts the course of a COVID infection:

  • T1D increases the risk of developing severe life-threatening illness or death by three to four times if you get a COVID-19 infection.
  • If you acquire the COVID-19 infection, increased glucose levels will limit your ability to receive ongoing care and/or services vital to your well-being and survival.
  • Accessing adequate and timely COVID care will be particularly challenging as a result of the impact COVID will have on your blood glucose levels.

Doctor’s Note

You will need to provide documentation that states that the medical provider’s clinical judgement is such that you meet one or more of the above listed qualifications. You can send the below draft letter (based on California’s requirements) to your doctor.

Make sure the note has the following:

  • Doctor’s Note on letterhead, dated and signed
  • It should state your name and specify your type 1 diabetes diagnosis
  • It should clearly state that you meet one or more of the specific qualifications and those qualifications should be described.

Draft Letter

[Date]

To Whom It May Concern,

This letter is to document that my patient [name] has type 1 diabetes (T1D) and has been under my care since [date].

Studies have shown that T1D can impact the course of a COVID-19 infection and meets the specific qualifications of the very highest risk for complications and death due to COVID-19:

  • T1D increases the risk of developing severe life-threatening illness or death by three to four times if you get a COVID-19 infection.
  • If you acquire the COVID-19 infection, increased glucose levels will limit your ability to receive ongoing care and/or services vital to your well-being and survival.
  • Accessing adequate and timely COVID care will be particularly challenging as a result of the impact COVID will have on your blood glucose levels.

Under those criteria, they should be considered for vaccine prioritization in Phase 1c.

Sincerely,

[Doctor’s Name and Office]